BioTelemetry (BEAT) Tops Q1 EPS by 1c

BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.02, $0.01 better than the analyst estimate of $0.01. Revenue for the quarter came in at $42.7 million versus the consensus estimate of $40.95 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Vail Resorts taps bankers for potential activist defense, Semafor reports
• FedEx (FDX) PT Lowered to $424 at Bernstein SocGen Group